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It is now established that fatty acid 7,10,13,16-22:4 is metabolized
into 4,7,10,13,16-22:5 as follows: 7,10,13,16-22:4! 9,12,15,18-
24:4! 6,9,12,15,18-24:5! 4,7,10,13,16-22:5. Neither C
#%
fatty
acid was esterified to 1-acyl-sn-glycero-3-phosphocholine (1-acyl-
GPC) by microsomes, whereas the rates of esterification of
4,7,10,13,16-22:5, 7,10,13,16-22:4 and 5,8,11,14-20:4 were res-
pectively 135, 18 and 160 nmol}min per mg of microsomal
protein. About four times as much acid-soluble radioactivity
was produced when peroxisomes were incubated with [3-"%C]-
9,12,15,18-24:4 compared with 6,9,12,15,18-24:5. Only
[1-"%C]7,10,13,16-22:4 accumulated when [3-"%C]9,12,15,18-24:4
was the substrate, but both 4,7,10,13,16-22:5 and 2-trans-
4,7,10,13,16-22:6 were produced from [3-"%C]6,9,12,15,18-24:5.
When the two C
#%
fatty acids were incubated with peroxisomes,
microsomes and 1-acyl-GPC there was a decrease in the prod-
uction of acid-soluble radioactivity from [3-"%C]6,9,12,15,18-
INTRODUCTION
Several studies have shown that microsomes do not contain an
acyl-CoA-dependent 4-desaturase [1–6]. When the fatty acids
7,10,13,16-22:4 and 7,10,13,16,19-22:5 are produced in the
endoplasmic reticulum, they are chain-elongated to 9,12,15,18-
24:4 and 9,12,15,18,21-24:5 respectively. These two acids are
subsequently desaturated at position 6 to yield 6,9,12,15,18-24:5
and 6,9,12,15,18,21-24:6 [1,2]. These endoplasmic reticulum-
derived metabolites must then move to a site, most probably the
peroxisomes, for partial β-oxidation [5,7]. The chain-shortened
metabolites formed by one or more cycles of β-oxidation are not
esterified into 1-acyl-sn-glycero-3-phosphocholine (1-acyl-GPC)
by peroxisomes [8], but rather they must move back to the
endoplasmic reticulum, where they are used for phospholipid
biosynthesis [8,9].
Prior to the discovery that microsomes do not have a 4-
desaturase, the biosynthesis of polyunsaturated fatty acids and
their incorporation into membrane lipids could be viewed as
processes that were both localized primarily in the endoplasmic
reticulum [10–12]. The revised pathways of unsaturated fatty
acid biosynthesis require considerable movement of fatty acids
between microsomes and peroxisomes [13]. Any given fatty acid
may be used as a substrate for a variety of different reactions.
For example, when [3-"%C]9,12,15,18-24:4 was incubated with
rat hepatocytes, only small amounts were esterified into phospho-
lipids, which is most probably a microsomal process. In addition,
it was possible to detect esterified [1-"%C]22:4,n®6 [2]. This
finding implies that, when 24:4,n®6 is produced in the en-
doplasmic reticulum (from 22:4,n®6), some of it must move
into the peroxisomes, where it is partially β-oxidized to
22:4,n®6; this then moves back to the endoplasmic reticulum,
Abbreviation used: 1-acyl-GPC, 1-acyl-sn-glycero-3-phosphocholine.
1 To whom correspondence should be addressed.
24:5, but not from [3-"%C]9,12,15,18-24:4. The preferential fate
of [1-"%C]4,7,10,13,16-22:5, when it was produced, was to move
out of peroxisomes for esterification into the acceptor, whereas
only small amounts of 7,10,13,16-22:4 were esterified. By using
#H-labelled 9,12,15,18-24:4 it was shown that, when 7,10,13,16-
22:4 was produced, its primary metabolic fate was degradation
to yield esterified arachidonate. Collectively, the results show
that an inverse relationship exists between rates of peroxisomal
β-oxidation and of esterification into 1-acyl-GPC by microsomes.
Most importantly, when a fatty acid is produced with its first
double bond at position 4, it preferentially moves out of
peroxisomes for esterification to 1-acyl-GPC by microsomes,
rather than being degraded further via a cycle of β-oxidation that
requires NADPH-dependent 2,4-dienoyl-CoA reductase.
where it may be used again as a substrate for either esterification
or chain elongation. In this type of study it is not possible to
determine how much [3-"%C]24:4,n®6 is metabolized to
20:4,n®6 via two cycles of β-oxidation, because of loss of the
label. In any case, when [3-"%C]24:4,n®6 was incubated with
hepatocytes, its major measurable fate was desaturation to
24:5,n®6 followed by partial β-oxidation to yield esterified [1-
"%C]22:5,n®6 [2]. When [3-"%C]24:5,n®6 was incubated with
hepatocytes, only small amounts were esterified into phospho-
lipids. Its major fate was metabolism to yield esterified [1-
"%C]22:5,n®6, but again it was not possible to detect product
formation after the second cycle of β-oxidation because of loss of
label [2].
In the study reported here, unsaturated fatty acids, labelled
with #H at the last two carbon atoms, as well as "%C-labelled acids,
were used to determine howperoxisomes andmicrosomes interact
to regulate the synthesis and subsequent esterification of long-




ATP, NAD+, NADPH, CoASH, dithiothreitol and essentially
fatty acid-free BSA were obtained from Sigma. Lactate de-
hydrogenase and Nycodenz (Accudenz) were obtained from
Boehringer Mannheim and Accurate Chemicals and Scientific
Corp. respectively. 1-Palmitoyl-2-sn-[1-oleoyl-"%C]glycero-3-
phosphocholine was from DuPont NEN. 1-Palmitoyl-2-sn-
[6,9,12,15-heneicosatetrenoyl]glycero-3-phosphocholinewas syn-
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thesized and purified as described by Paltauf and Hermetter
[14]. [19,19,20,20-#H
%
]Ethyl arachidonate [15] was converted into
[23,23,24,24-#H
%
]9,12,15,18-tetracosatetraenoic acid via a se-
quence of reactionswhereby the ethyl ester of labelled arachidonic
acid was reduced to the alcohol with LiAlH
%
. The resulting
alcohol was converted into the mesylate, which was displaced
with cyanide. Following hydrolysis with 5% anhydrous HCl in
methanol, the methyl ester of the labelled C
#"
acid was obtained
[16]. This sequence of reactions was repeated three more times to
yield the desired product. All 1-"%C- and 3-"%C-labelled acids
were made by total organic synthesis [16].
Isolation of rat liver peroxisomes and microsomes
Male Sprague–Dawley rats (200–250 g) were fed on Purina chow
without or with 0.5% (w}v) clofibrate for 8 days prior to being
killed. In essence, the procedure of Das et al. [12], as previously
described [17], was used to isolate peroxisomes. Briefly, liver was
homogenized in a medium containing 0.25 M sucrose, 1 mM
EDTA, 0.1% ethanol and 10 mM Tes, pH 7.5. Nuclei and the
heavy mitochondrial fraction obtained by centrifugation at 600 g
and 3300 g respectively were discarded. The light mitochondrial
pellet obtained by centrifugation at 25000 g for 17 min was
resuspended in the homogenization buffer and centrifuged at
25000 g for 15 min. One additional wash was done under the
same conditions. The resulting pellet was then resuspended in
the homogenization buffer in a volume corresponding to 1 ml for
every 2 g of liver. A 2 ml portion of this suspension was then
layered on to 15 ml of 35% (w}v) Nycodenz containing 10 mM
Tes, 0.1% ethanol and 1 mM EDTA, and centrifuged at 56800 g
for 45 min. The resulting peroxisomal pellet was suspended in
incubation medium, which contained 130 mM KCl and 20 mM
Hepes, pH 7.2 [18]. The protein concentration was adjusted to
3 mg}ml, as determined by using the Coomassie Blue reagent
(Pierce) with BSA as a standard. In order to prepare microsomes,
the 25000 g supernatant was centrifuged at 110000 g for 45 min.
The microsomal pellet was suspended in 0.6 M KCl}0.1 M
phosphate buffer, pH 7.4. After centrifugation at 110000 g for
45 min, the microsomal pellet was suspended in 130 mM
KCl}20 mM Hepes, pH 7.2, and stored at ®80 °C.
Fatty acid activation
Peroxisomes (10 or 50 µg of protein) were incubated in a total
volume of 0.2 ml in a medium that contained 130 mM KCl,
20 mM Hepes, 10 mM MgATP, 0.4 mM CoASH and the sodium
salt of the radioactive fatty acid (2 Ci}mol) bound to BSA in a
2:1 molar ratio (assuming an M
r
of 66000 for BSA). Reactions
were initiated by the addition of peroxisomes. The fatty acid
concentration varied from 12.5 to 150 µM. After 2 min the





(40:10:1, by vol.), followed by
1.5 ml of n-heptane and 1 ml of water. The upper layer, con-
taining the unreacted fatty acid, was discarded and the bottom
layer was washed twice with 2 ml of heptane [19]. The
bottom layers, containing the acyl-CoAs, were transferred to scin-
tillation vials and radioactivity was counted in 10 ml of ACS
II (Amersham). Maximum rates of activation were calculated
from double-reciprocal plots.
Microsomal acylation of 1-acyl-GPC
The CoA derivatives of fatty acids were synthesized via their
mixed anhydrides [20]. Maximum rates of acylation were de-
termined spectrophotometrically [21]. Incubations contained
50 µM acyl-CoA, 300 µM 1-acyl-GPC, 2 mM 5,5-dithiobis-(2-
nitrobenzoic acid) and 25–200 µg of microsomal protein in 1 ml
of 0.1 M Tris}HCl (pH 7.4).
Peroxisomal metabolism
The sodium salts of fatty acids bound to BSA in a 2:1 molar
ratio were preincubated at 37 °C in a medium that contained
130 mM KCl, 20 mM Hepes (pH 7.2), 0.1 mM EGTA, 0.5 mM
NAD+, 0.2 mM NADPH, 0.4 mM CoASH, 10 mM MgATP,
0.1 mM dithiothreitol, 20 mM pyruvate and 2 units of lactate
dehydrogenase [17,18]. Reactions were initiated by the addition
of 300 µg of peroxisomal protein. Other incubations also con-
tained 300 µg of microsomal protein and 100 nmol of 1-acyl-
GPC. The final incubation volume was always 1 ml. At various
times, 200 µl aliquots were removed and mixed with an equal
volume of 5% HClO
%
. After 30 min at 4 °C, the samples were
centrifuged and 200 µl aliquots were counted to measure acid-
soluble radioactivity.
In order to quantify the esterification of metabolites into 1-
acyl-GPC, the reactions were terminated by the addition of
3.3 ml of chloroform and 6.7 ml of methanol, followed by
the addition of 100000 d.p.m. of 1-palmitoyl-2-sn-[1-"%C-
oleoyl]glycero-3-phosphocholine as an internal standard. The
tubes were centrifuged and the bottom layer was taken to dryness
under a stream of N
#
. The lipids were dissolved in chloroform,
and neutral lipids were separated from phospholipids by sequen-
tial elution of Pasteur pipettes packed with Unisil (Clarkson
Chemicals) with 10 ml each of chloroform and methanol. The
methanol was removed under N
#
and the phospholipids were
inter-esterified by stirring them with 5% anhydrous HCl in
methanol overnight. The methyl esters were recovered by ex-
traction with hexane and separated by reverse-phase HPLC on a
0.46 cm¬25 cm Zorbax ODS column using acetonitrile}water
(9:1, v}v), at 1 ml}min, as the eluting solvent. The effluent was
mixed with ScintiVerse LC (Fisher) at 3 ml}min, and radio-
activity was detected with a Beckman 171 radioisotope detector.
The esterified metabolites were quantified (nmol) from the
amount of radioactivity that was associated with methyl oleate.
When [23,23,24,24-#H
%
]24:4,n®6 was used as a substrate, the
reaction was again terminated by the addition of chloroform and
methanol, but 235 nmol of 1-palmitoyl-2-sn-[6,9,12,15-hene-
icosatetraenoyl]glycero-3-phosphocholine was added as an inter-
nal standard. The phospholipids were then saponified by stirring
them with 4% KOH in methanol}water (96:4, v}v). After
acidification with HCl, the non-esterified fatty acids were re-
covered by extraction with hexane}diethyl ether (9:1, v}v). The
fatty acids were then derivatized by heating them at 60 °C for
30 min with 100 µl each of acetonitrile and N-methyl-N-
(t-butyldimethylsilyl)trifluoracetamide. The excess derivatizing
reagent was removed under a stream of N
#
and the compounds
were dissolved in iso-octane.
MS was carried out with a Hewlett–Packard model 5970 mass
selective detector and a 5790 gas chromatograph containing a
30 m¬0.25 mm inside DB-5ms capillary column (J. and W.
Scientific, Rancho Cordoba, CA, U.S.A.). Compounds were
injected in the splitless mode at 70 °C. After 3 min the oven was
programmed to increase to 250 °C at 15 °C}min. The amounts of
various metabolites were quantified by monitoring the appro-
priate M®57 ions [22].
RESULTS
Microsomal esterification of fatty acids into 1-acyl-GPC
Our previous studies have shown that arachidonic acid is
metabolized via 22:4,n®6 to 24:4,n®6 and 24:5,n®6 in the
4274,7,10,13,16-Docosapentaenoic acid biosynthesis
Table 1 Rates of acylation of fatty acids into 1-acyl-GPC by liver
microsomes from rats fed on Purina chow with and without 0.5% (w/v)
clofibrate
Microsomes were incubated with acyl-CoAs and 1-acyl-GPC in the presence of 5,5«-dithiobis-
(2-nitrobenzoic acid). Rates of reaction were determined spectrophotometrically, and are
means³S. E. M. of three separate experiments.
Acylation (nmol/min per mg of microsomal protein)
Acyl-CoA Chow diet Chow diet­0.5% clofibrate
20 :4,n®6 52.7³2.2 159.8³8.8
22 :4,n®6 6.0³1.6 18.4³4.1
22 :5,n®6 49.8³5.4 134.9³3.3
24 :4,n®6 1.3³0.2 1.0³0.4
24 :5,n®6 1.1³0.3 0.9³0.4
Table 2 Rates of activation of fatty acids by peroxisomes from rats fed on
Purina chow with or without 0.5% (w/v) clofibrate
Results are means³range of two separate experiments.
Activation
(nmol/min per mg of peroxisomal protein)
Fatty acid Control ­Clofibrate
[1-14C]20 :4 185³19 314³27
[1-14C]22 :4 49³12 103³6
[1-14C]22 :5 45³2 86³8
[3-14C]24 :4 9³4 18³2
[3-14C]24 :5 7³1 9³1
endoplasmic reticulum [2]. If either of these two C
#%
acids were
used for membrane lipid biosynthesis where they are produced,
it would curtail their rapid movement to a site for partial β-
oxidation. The results in Table 1 show that neither C
#%
acid was
esterified into 1-acyl-GPC by microsomes from rats fed on diets
with or without clofibrate. When arachidonic acid and the two
C
##
acids were the substrates, there was an approx. 3-fold
increase in rates of acylation with microsomes from rats fed on
a clofibrate-containing diet compared with microsomes from rats
fed on chow.
Fatty acid activation
Since 24:4,n®6 is a poor substrate for acylation into 1-acyl-
GPC, the above results imply that, in io, it must either be
desaturated at position 6 to yield 24:5,n®6 or move to
peroxisomes for partial β-oxidation to 22:4,n®6. The primary
metabolic fate of 24:5,n®6 must be to move to a site for partial
degradation. The true substrates and products for a number of
microsomal desaturation and chain-elongation reactions are the
acyl-CoAs [23–25]. Presumably when C
#%
acids are produced in
the endoplasmic reticulum, they also are acyl-CoAs. Cytosol
contains acyl-CoA hydrolases [26,27]. It is not known whether
acyl-CoAs can move directly into peroxisomes, or whether they
are hydrolysed and subsequently re-activated by the subcellular
organelle in which they are to be metabolized. The results in







acids, albeit at markedly different rates. As was
observed for rates of microsomal acylation, the addition of
clofibrate to the diet increased the rates of activation. This effect
Figure 1 Time-dependent β-oxidation of [1-14C]7,10,13,16-22 :4 (A), [1-
14C]4,7,10,13,16-22 :5 (B), [3-14C]9,12,15,18-24 :4 (C) and [3-14C]-
6,9,12,15,18-24 :5 (D)
Peroxisomes (300 µg of protein) from rats fed on a diet of Purina chow (D) or one containing
clofibrate (*) were incubated with 100 µM substrate. In addition, 300 µg of peroxisomal
protein from rats fed clofibrate were incubated with 300 µg of microsomal protein and 100 µM
1-acyl-6PC (^). Results are means³range for two separate experiments.




acids than for the C
#%
compounds. Microsomes, mitochondria and peroxisomes all
contain a long-chain acyl-CoA synthetase [28,29]. Peroxisomes
and microsomes, but not mitochondria, contain an enzyme that
is designated as a very-long-chain acyl-CoA synthetase [30]. The
above studies do not discriminate between these two enzyme
activities. Since all of the n®6 acids were activated by
peroxisomes, all subsequent studies were carried out by gen-
erating acyl-CoAs in situ, which may well be the case in io.
Peroxisomal fatty acid β-oxidation and the esterification of chain-
shortened acids into 1-acyl-GPC by microsomes
The results in Figure 1 show that with all four n®6 acids the
addition of clofibrate to the diet increased the rate of peroxisomal
β-oxidation. When clofibrate was included in the diet, about
30 nmol of acid-soluble radioactivity was produced from
[1-"%C]7,10,13,16-22:4 at 5 min (Figure 1A), compared with only
about 2 nmol when [1-"%C]4,7,10,13,16-22:5 was the substrate
(Figure 1B). Similar differences existed for the two C
#%
acids:
after 5 min, about eight times as much acid-soluble radioactivity
was produced from [3-"%C]9,12,15,18-24:4 as from [3-"%C]-
6,9,12,15,18-24:5 (Figures 1C and 1D respectively).
The results in Figure 1 show that, when peroxisomes from rats
fed on a clofibrate-containing diet were incubated with micro-
somes and 1-acyl-GPC, there was only a small decrease in the
production of acid-soluble radioactivity from [1-"%C]7,10,13,16-
22:4 (Figure 1A) or [3-"%C]9,12,15,18-24:4 (Figure 1C). The loss
of label from these two fatty acids requires only the enzymes of
saturated fatty acid degradation. Conversely, when [1-
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Table 3 Incorporation of radioactive fatty acids into phospholipids on
incubation of peroxisomes with 1-acyl-GPC and microsomes
Peroxisomes (300 µg of protein) from rats fed on Purina chow containing 0.5% (w/v) clofibrate
were incubated with 100 µM fatty acid, 100 µM 1-acyl-GPC and 300 µg of microsomal protein.
After 30 min, the incubations were terminated by the addition of chloroform and methanol,
followed by the addition of 100000 d.p.m. of 1-palmitoyl-2-[1-14C-oleoyl]-sn-glycero-3-
phosphocholine. The phospholipids were separated by silicic acid column chromatography and
inter-esterified. The amounts of esterified acids were calculated from the amounts of radioactivity
associated with the methyl oleate in the HPLC radiochromatograms. Results are means³range
from two separate experiments.
Esterified radioactive fatty acid (nmol)
Substrate 22 :4,n®6 24 :4,n®6 22 :5,n®6 24 :5,n®6
[1-14C]22 :4,n®6 15.8³0.3 – – –
[3-14C]24 :4,n®6 9.0³1.0 3.2³1.4 – –
[1-14C]22 :5,n®6 – – 39.9³3.3 –
[3-14C]24 :5,n®6 – – 31.8³3.3 2.2³0.6
"%C]4,7,10,13,16-22:5 (Figure 1B) or [3-"%C]6,9,12,15,18-24:5
(Figure 1D) was incubated with peroxisomes, microsomes and 1-
acyl-GPC, there was a marked decrease in the production of
acid-soluble radioactivity. The first cycle of β-oxidation of
6,9,12,15,18-24:5 also uses only the enzymes of saturated fatty
acid degradation but, as soon as 4,7,10,13,16-22:5 is produced,
its continued degradation requires both NADPH-dependent 2,4-
dienoyl-CoA reductase and ∆$,∆#-enoyl-CoA isomerase, which is
a component of the peroxisomal trifunctional enzyme [31].
Table 3 compares the amounts of labelled acids esterified into
phospholipids when peroxisomes were incubated with micro-
somes and 1-acyl-GPC. When [1-"%C]22:4,n®6 was the substrate,
there was only a small decrease in the production of acid-soluble
radioactivity when incubations contained microsomes and 1-
acyl-GPC (Figure 1A). After 30 min, 15.8 nmol of 22:4,n®6 had
been esterified into phospholipids (Table 3), which is equal to the
difference in the production of acid-soluble radioactivity when
peroxisomes were incubated with and without microsomes and
1-acyl-GPC. When [1-"%C]4,7,10,13,16-22:5 was incubated di-
rectly with peroxisomes, microsomes and 1-acyl-GPC, or
generated from [3-"%C]6,9,12,15,18-24:5, its primary fate was
esterification rather than continued β-oxidation. For example, at
30 min about 3 nmol of acid-soluble radioactivity had been
produced from [3-"%C]24:5,n®6 (Figure 1D), but 31.8 nmol of
22:5,n®6 was esterified (Table 3). Only small amounts of the
two C
#%
acids were directly esterified. When [3-"%C]24:4,n®6 was
the substrate, the preferred metabolic fate of [1-"%C]22:4,n®6,
when it was generated, was continued β-oxidation rather than
esterification, since after 30 min only 9 nmol had been esterified.
Characterization of metabolites produced on incubation of [1-14C]-
4,7,10,13,16-22 :5 and [3-14C]6,9,12,15,18-24 :5 with peroxisomes
When [1-"%C]22:4,n®6 was incubated alone with peroxisomes, it
was only possible to detect unmetabolized substrate when the
methyl esters, formed by saponification and subsequent esterifica-
tion, were analysed by HPLC. When [3-"%C]24:4,n®6 was the
substrate it was possible to detect both unmetabolized substrate
and [1-"%C]22:4,n®6. When [1-"%C]22:5,n®6 was incubated with
peroxisomes, three radioactive metabolites were eluted immedi-
ately before unmetabolized substrate (Figure 2A). When [3-
"%C]24:5,n®6 was incubated under the same conditions, it was
possible to detect the same three compounds in addition to [1-
Figure 2 HPLC radiochromatograms obtained on incubation of 100 µM
[1-14C]4,7,10,13,16-22 :5 (A) or [3-14C]6,9,12,15,18-24 :5 (B) with 300 µg of
peroxisomal protein from rats fed on a clofibrate-containing diet
The incubations were terminated after 30 min, and methyl esters were prepared and analysed
by HPLC. Compounds 1 and 2 are isomers of 3,5,7,10,13,16-22 : 6, and compounds 3, 4 and
5 are 2-trans-4,7,10,13,16-22 : 6, 22 : 5,n®6 and 24 :5,n®6 respectively.
"%C]22:5,n®6, i.e. compound 4 in Figure 2(B). The UV spectrum
of compound 3 was identical with that of authentic methyl-2-
trans-4-cis-10:2, which was isolated from the seed oil of the
Chinese tallow tree [32]. Compound 3 is thus 2-trans-4,7,10,13,16-
22:6, which is the substrate for NADPH-dependent 2,4-dienoyl-
CoA reductase. Compounds 1 and 2 had absorbance maxima at
257, 267 and 277 nm, showing that they contained three double
bonds in conjugation, and are thus probably isomers of
3,5,7,10,13,16-22:6 [9]. These compounds are most likely formed
from 2-trans-4,7,10,13,16-22:6 by peroxisomal ∆$,&,∆#,%-dienoyl-
CoA isomerase [33] operating in the reverse direction.
Metabolism of 2H-labelled 9,12,15,18-24 :4
Since the production of acid-soluble radioactivity from [1-
"%C]7,10,13,16-22:4 and [3-"%C]9,12,15,18-24:4 was not markedly
reduced when incubations also contained microsomes and 1-
acyl-GPC, subsequent incubations were carried out with
[23,23,24,24-#H
%
]9,12,15,18-24:4. In these experiments we com-
pared the amount of acid-soluble radioactivity produced when
[3-"%C]9,12,15,18-24:4 was incubated with peroxisomes, micro-




]5,8,11,14-20:4 esterified in phospholipids. In four separate
experiments in which 100 nmol of the substrate was incubated
for 30 min with 300 µg each of microsomal and peroxisomal
protein and 100 µM 1-acyl-GPC, it was observed that
19.2³1.4 nmol (mean³S.E.M.) of acid-soluble radioactivitywas
produced. With the #H-labelled substrate, 15.2³1.5 nmol of
labelled arachidonate was esterified. The data clearly show that,
when 9,12,15,18-24:4 is the substrate, it is degraded rapidly via
two cycles of β-oxidation, but once arachidonate is produced its
primary metabolic fate is to move out of peroxisomes for
acylation into 1-acyl-GPC.
Competition studies with C24 fatty acids
All of the above studies were carried out using a single substrate.
In io, when C
#%
acids are produced, the possibility exists that
both 24:4,n®6 and 24:5,n®6 could move into peroxisomes and
compete for partial β-oxidation to yield, respectively, 22:4,n®6
and 22:5,n®6, both of which have the potential of serving as
substrates for continued β-oxidation or being transferred back to
the endoplasmic reticulum for esterification into 1-acyl-GPC.
When 100 nmol of [3-"%C]9,12,15,18-24:4 and [3-"%C]-
6,9,12,15,18-24:5were incubated together for 30 minwith peroxi-
somes, microsomes and 1-acyl-GPC, 1.8³0.2 and 12.4³
2.4 nmol respectively of 7,10,13,16-22:4 and 4,7,10,13,16-22:5
was esterified in phospholipids. As expected, these esterification
values, which are averages (³range) of two separate experiments,
were lower than those obtained when 100 nmol of [3-
"%C]24:4,n®6 or [3-"%C]25:5,n®6 was incubated individually
under these conditions (Table 3). When the two 3-"%C-labelled
C
#%
acids are incubated together, the first cycle of β-oxidation of
both substrates requires only the enzymes of saturated fatty acid
oxidation, and thus it is expected that, due to substrate com-
petition, smaller amounts of each substrate would be degraded to
yield C
##
acids than when they are incubated alone. However, the
important point of these studies is that the ratio of esterified
22:5,n®6}22:4,n®6 was similar when the two 3-"%C-labelled
fatty acids were incubated together (i.e. 12.2}1.8¯ 6.7) and
when they were incubated separately (39.9}9¯ 4.4).
The synthesis of 22:6,n®3 from 24:6,n®3 [9] proceeds via a
pathway analogous to that for the production of 22:5,n®6.
When experiments identical to those described above were carried
out with [3-"%C]9,12,15,18,21-24:5 and [3-"%C]6,9,12,15,18,21-
24:6, it was found that 1.6³1.2 and 9.0³0.2 nmol respectively
of 7,10,13,16,19-22:5 and 4,7,10,13,16,19-22:6 was esterified. As
with the n®6 acids, there was enhanced esterification of the
metabolite, i.e. 22:6,n®3, whose continued peroxisomal degra-
dation requires NADPH-dependent 2,4-dienoyl-CoA reductase
activity.
When 22:5,n®6 and 22:6,n®3 are produced from their C
#%
precursors, their continued peroxisomal degradation requires
NADPH-dependent 2,4-dienoyl-CoA reductase. Experiments
were thus carried out to determine if there was preferential
esterification of either 22:5,n®6 or 22:6,n®3 when [3-
"%C]24:5,n®6 and [3-"%C]24:6,n®3 were incubated together with
microsomes, peroxisomes and 1-acyl-GPC. Because of chromato-
graphic overlap problems, these studies were carried out by
incubating 100 nmol of a labelled fatty acid with an equal
amount of the appropriate unlabelled analogue. In two separate
experiments it was observed that, when 100 nmol of [3-
"%C]24:5,n®6 was incubated with an equal amount of unlabelled
24:6,n®3, 12.2 and 8.5 nmol respectively of 22:5,n®6 was
esterified after a 30 min incubation. In the direct crossover study
using [3-"%C]24:6,n®3 and unlabelled 24:5,n®6, 10.2 and
12.0 nmol respectively of 22:6,n®3 was esterified in two separate
experiments. Under these conditions there were no differences in
the amounts of 22:5,n®6 and 22:6,n®3 esterified when they





When hepatocytes were incubated with 3-"%C-labelled C
#%
n®3
[1] and n®6 [2] fatty acids, only small amounts of the substrates
were esterified directly into phospholipids. In the present study,
as well as in an analogous study with labelled n®3 fatty acids [9],
it was observed that these compounds were poor substrates for
esterification into 1-acyl-GPC by microsomal acyl-CoA:1-acyl-
GPC acyltransferase. When C
#%
acids are produced in the
endoplasmic reticulum, their primary metabolic fate must be to
move to another intracellular site for further metabolism. It
remains to be determined whether they move as acyl-CoAs or
whether they are hydrolysed in the cytosol [26,27] and re-
activated at their site of subsequent metabolism. It also remains
to be determined whether mitochondria, which lack a very-long-
chain acyl-CoA synthetase [30], have the capacity to activate
unsaturated C
#%
acids, convert them into acylcarnitines and
subsequently degrade them completely, which would appear to
be an example of futile metabolite cycling.
The results obtained here, as well as with the corresponding
n®3 fatty acids [9], generally show that an inverse relationship
exists between rates of peroxisomal β-oxidation and rates
of microsomal esterification into 1-acyl-GPC. When [3-
"%C]24:4,n®6 was incubated with peroxisomes, the addition of
microsomes and 1-acyl-GPC did not markedly decrease the
production of acid-soluble radioactivity. The β-oxidation of
24:4,n®6 to 20:4,n®6 requires only the enzymes of saturated
fatty acid degradation. Neither 24:4,n®6 nor 22:4,n®6, the
product formed after one cycle of β-oxidation, was readily
esterified into 1-acyl-GPC. By using #H-labelled 24:4,n®6 it was
shown that the primary metabolic fate of 20:4,n®6, when it
was produced, was esterification rather than continued pero-
xisomal degradation. The first cycle of [3-"%C]24:5,n®6 β-
oxidation also uses only the enzymes of saturated fatty acid
degradation. When [3-"%C]24:5,n®6 was incubated with pero-
xisomes, microsomes and 1-acyl-GPC, there was a marked
decrease in the production of acid-soluble radioactivity, which
would be produced during the second cycle of fatty acid
degradation. As soon as 22:5,n®6 is produced, it is preferentially
transferred out of peroxisomes and used as a substrate for
esterification in microsomes rather than undergoing continued
peroxisomal β-oxidation. Since peroxisomes do not contain acyl-
CoA:1-acyl-GPC acyltransferase [8], the chain-shortened pro-
duct must then be transferred back to the endoplasmic reticulum
for use in membrane lipid biosynthesis.
It appears that the low activity of peroxisomal NADPH-
dependent 2,4-dienoyl-CoA reductase is a major control point
in the regulation of peroxisomal β-oxidation. When [1-




Similar results were obtained with the analogous n®3 fatty
acids, i.e. [3-"%C]24:6,n®3 and [1-"%C]22:6,n®3 [9]. When 3-"%C-
labelled 24:4,n®6 and 24:5,n®6 were incubated together in the
presence of microsomes and 1-acyl-GPC, there was preferential
esterification of 22:5,n®6 compared with 22:4,n®6. Similar
results were obtained when 3-"%C-labelled 24:5,n®3 and
24:6,n®3 were incubated together. When [1-"%C]16:3,n®6, the
product formed after two cycles of arachidonate β-oxidation,
was incubated with peroxisomes, 2-trans-4,7,10-16:4 accumu-
lated [9]. It was possible to detect labelled 4,7,10-16:3 in the
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medium when control fibroblasts, but not those from patients
with Zellweger’s syndrome, were incubated with $H-labelled
arachidonic acid [34]. Collectively, the above findings suggest
that, when an acid is produced in peroxisomes with its first
double bond at position 4, its further degradation is impaired,
since the next cycle requires the action of NADPH-dependent
2,4-dienoyl-CoA reductase. As a result, that fatty acid is preferen-
tially transported out of peroxisomes, via some unknown path-
way, for use in another subcellular compartment, such as for
rapid acylation, as was observed when 22:5,n®6 was produced
from 24:5,n®6.
It has generally been recognized that desaturation of linoleate
and linolenate at position 6 is the rate-limiting step in the
biosynthesis of long-chain n®6 and n®3 fatty acids [35–37].
When rats are raised on a chow diet, their liver phospholipids
contain large amounts of arachidonate, but small amounts of
both 22:4,n®6 and 22:5,n®6. Conversely, the same membrane
lipids contain little if any 20:5,n®3 and small amounts of
22:5,n®3, but 22:6,n®3 is a major component. Although the
pathways for 22:5,n®6 and 22:6,n®3 biosynthesis are identical,
no single reaction rate for any reaction can explain these
compositional differences. Reaction rates for the desaturation of
24:4,n®6 and 24:5,n®3 at position 6 were similar. Moreover
these rates were similar to those for the desaturation of linoleate
and linolenate at position 6 [38]. Reaction rates for chain
elongation of 20:4,n®6 and 20:5,n®3 were similar to each
other, but about 5-fold greater than those for chain elongation of
22:4,n®6 and 22:5,n®3 [2]. None of these reaction rates in
themselves can be used as reliable indicators to predict why
membrane lipids accumulate specific fatty acids. In a similar
way, the reaction rates for the esterification of analogous n®3
and n®6 fatty acids into 1-acyl-GPC were similar, and could not
be used as predictors as to why membrane lipids accumulate
specific unsaturated fatty acids [21]. In the study reported here,
it was found that there was no selectivity in the degradation of 3-
"%C-labelled 24:5,n®6 and 24:6,n®3 to their respective 1-"%C-
labelled fatty acids followed by their movement out of
peroxisomes for esterification into 1-acyl-GPC. The fatty acids
22:4,n®6 and 22:5,n®3 may be viewed as central intermediates
in determining how much 22:5,n®6 and 22:6,n®3 is produced.
Both 22:4,n®6 and 22:5,n®3, when produced in microsomes,
may be esterified directly, partially β-oxidized to yield 20:4,n®6
and 20:5,n®3, which can be esterified, or metabolized into
24:5,n®6 and 24:6,n®3, which are esterified following chain
shortening. When [3-"%C]22:4,n®6 was injected into the tail vein
of rats fed a chow diet, 96 and 4% respectively of the esterified
radioactivity in liver phospholipids was arachidonate and un-
metabolized substrate. When [3-"%C]22:5,n®3 was injected, 20,
56 and 24% respectively of the esterified radioactivity was
20:5,n®3, 22:5,n®3 and 22:6,n®3 [39]. Clearly there are
differences in how these two central intermediates aremetabolized
in io that, at present, cannot be explained by any individual
reaction in either microsomes or peroxisomes.
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